guhjy's surrogate [72 articles] Export

Recent papers added to guhjy's library classified by the tag surrogate. You can also see everyone's surrogate.

	Hypertension and Diabetes: what are the pros to treating early surrogates? [My Copy] Diabetes care, Vol. 32 Suppl 2 (November 2009) by Roland E. Schmieder posted to uae surrogate dm bp by guhjy on 2009-11-15 05:08:11 as
	Hypertension and diabetes: should we treat early surrogates? What are the cons? [My Copy] Diabetes care, Vol. 32 Suppl 2 (November 2009) by Peter M. Nilsson posted to uae surrogate dm bp by guhjy on 2009-11-15 05:08:02 as
	Surrogate end points and long-term outcome in patients with chronic hepatitis B. [My Copy] Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, Vol. 7, No. 10. (October 2009), pp. 1113-1120. by Vincent Wai-Sun W. Wong, Grace Lai-Hung L. Wong, Angel Mei-Ling M. Chim, et al.Paul Cheung-Lung C. Choi, Anthony Wing-Hung W. Chan, Steven Woon-Choy W. Tsang, Alex Yui Y. Hui, Hoi-Yun Y. Chan, Joseph Jao-Yiu J. Sung, Henry Lik-Yuen L. Chan posted to surrogate rct hbv by guhjy on 2009-10-29 02:25:25 as
	A Bayesian Approach to Surrogacy Assessment Using Principal Stratification in Clinical Trials. [My Copy] Biometrics (10 August 2009) by Yun Li, Jeremy M. Taylor, Michael R. Elliott posted to surrogate rct bayes by guhjy on 2009-10-07 05:45:46 as
	The use of surrogate outcomes in model-based cost-effectiveness analyses: a survey of UK Health Technology Assessment reports. [My Copy] Health technology assessment (Winchester, England), Vol. 13, No. 8. (January 2009) by R. S. Taylor, J. Elston posted to surrogate cea by guhjy on 2009-09-27 11:12:18 as
	Surrogate markers in clinical trials--challenges and opportunities. [My Copy] Atherosclerosis, Vol. 206, No. 1. (September 2009), pp. 8-16. by Raphaël Duivenvoorden, Eric de Groot, Erik S. Stroes, John J. Kastelein posted to surrogate rct by guhjy on 2009-09-02 07:00:55 as along with 1 person booker
	Proteinuria as a surrogate outcome in CKD: report of a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration. [My Copy] American journal of kidney diseases : the official journal of the National Kidney Foundation, Vol. 54, No. 2. (August 2009), pp. 205-226. by Andrew S. Levey, Daniel Cattran, Aaron Friedman, et al.W. Greg Miller, John Sedor, Katherine Tuttle, Bertram Kasiske, Thomas Hostetter posted to ckd proteinuria surrogate by guhjy on 2009-07-22 03:06:38 as
	Proteinuria as a Surrogate Outcome in CKD: Report of a Scientific Workshop Sponsored by the National Kidney Foundation and the US Food and Drug Administration [My Copy] Am J Kidney Dis (2009) by Andrew S. Levey, Daniel Cattran, Aaron Friedman, et al.W. Greg Miller, John Sedor, Katherine Tuttle, Bertram Kasiske, Thomas Hostetter posted to ckd doqi proteinuria surrogate uae by guhjy on 2009-07-06 10:50:50 as
	Surrogate and Mediating Endpoints: Current Status and Future Directions [My Copy] J. Natl. Cancer Inst., Vol. 101, No. 4. (18 February 2009), pp. 216-217. by Ross L. Prentice posted to surrogate by guhjy on 2009-03-24 05:02:31 as along with 1 person misonneh
	Evaluation of surrogate endpoints in randomized experiments with mixed discrete and continuous outcomes. [My Copy] Statistics in medicine, Vol. 20, No. 20. (30 October 2001), pp. 3023-3038. by G. Molenberghs, H. Geys, M. Buyse posted to surrogate by guhjy on 2009-03-24 04:58:12 as
	Statistical validation of endophenotypes using a surrogate endpoint analytic analogue [My Copy] Genetic Epidemiology, Vol. 9999, No. 9999. (2009), n/a. by Guan-Hua Huang, Chin-Chiang Hsieh, Chen-Hsin Chen, Wei J. Chen posted to genetics phenotype surrogate by guhjy on 2009-03-15 12:12:57 as along with 1 person pkonings
	How can biomarkers become surrogate endpoints? [My Copy] European Journal of Cancer Supplements, Vol. 5, No. 9. (December 2007), pp. 37-40. by B. Berns, P. Demolis, M. Scheulen posted to biomarker surrogate by guhjy on 2009-03-02 15:33:57 as
	Surrogate markers and joint models for longitudinal and survival data [My Copy] Controlled Clinical Trials, Vol. 23, No. 6. (December 2002), pp. 626-634. by J. Taylor posted to cox joint-model surrogate longitudinal by guhjy on 2009-03-02 14:18:29 as
	The meta-analytic framework for the evaluation of surrogate endpoints in clinical trials [My Copy] Journal of Statistical Planning and Inference, Vol. 138, No. 2. (01 February 2008), pp. 432-449. by G. Molenberghs, T. Burzykowski, A. Alonso, P. Assam, A. Tilahun, M. Buyse posted to met-analysis surrogate by guhjy on 2009-03-02 14:17:00 as
	Considerations in the Evaluation of Surrogate Endpoints in Clinical Trials Summary of a National Institutes of Health Workshop [My Copy] Controlled Clinical Trials, Vol. 22, No. 5. (October 2001), pp. 485-502. by V. De Gruttola posted to rct surrogate by guhjy on 2009-03-02 14:16:47 as
	The Sudden Demise of Dual Renin-Angiotensin System Blockade or the Soft Science of the Surrogate End Point [My Copy] Journal of the American College of Cardiology, Vol. 53, No. 6. (10 February 2009), pp. 468-470. by Franz H. Messerli posted to aceiarb rct surrogate by guhjy on 2009-02-10 10:25:09 as
	Blood pressure as an example of a biomarker that functions as a surrogate [My Copy] The AAPS Journal, Vol. 8, No. 1. (27 March 2006), pp. E146-E152. by Mehul Desai, Norman Stockbridge, Robert Temple posted to bp cv surrogate by guhjy on 2009-02-10 09:27:25 as
	Surrogate markers in clinical studies: problems solved or created? [My Copy] American journal of kidney diseases : the official journal of the National Kidney Foundation, Vol. 48, No. 1. (July 2006), pp. 159-166. by B. Manns, W. F. Owen, W. C. Winkelmayer, P. J. Devereaux, M. Tonelli posted to surrogate by guhjy on 2009-02-10 06:47:53 as
	Biomarkers and Surrogate Endpoints in Clinical Drug Development [My Copy] posted to surrogate by guhjy on 2009-02-10 06:45:57 as
	Are surrogate markers adequate to assess cardiovascular disease drugs? [My Copy] JAMA : the journal of the American Medical Association, Vol. 282, No. 8. (25 August 1999), pp. 790-795. by R. Temple posted to cv rct surrogate by guhjy on 2009-02-10 03:18:04 as
	Response rate or time to progression as predictors of survival in trials of metastatic colorectal cancer or non-small-cell lung cancer: a meta-analysis. [My Copy] The lancet oncology, Vol. 7, No. 9. (September 2006), pp. 741-746. by K. R. Johnson, C. Ringland, B. J. Stokes, et al.D. M. Anthony, N. Freemantle, A. Irs, S. R. Hill, R. L. Ward posted to rct surrogate by guhjy on 2009-02-03 15:58:22 as
	On the use of surrogate end points in randomized trials [My Copy] Journal of the Royal Statistical Society: Series A (Statistics in Society), Vol. 163, No. 1. (2000), pp. 15-28. by C. B. Begg, D. H. Y. Leung posted to rct surrogate by guhjy on 2009-01-24 04:04:52 as
	Surrogate End Points in Clinical Trials: Are We Being Misled? [My Copy] Annals of Internal Medicine, Vol. 125, No. 7. (1 October 1996), pp. 605-613. by Thomas R. Fleming, David L. DeMets posted to surrogate by guhjy on 2009-01-24 04:03:49 as along with 1 person cyberwulf
	Quantification of the Prentice Criteria for Surrogate Endpoints [My Copy] Biometrics, Vol. 62, No. 1. (March 2006), pp. 297-300. by O'Quigley, John, Flandre, Philippe posted to surrogate by guhjy on 2009-01-24 03:45:33 as
	Hematocrit was not validated as a surrogate end point for survival among epoetin-treated hemodialysis patients. [My Copy] Journal of clinical epidemiology, Vol. 57, No. 10. (October 2004), pp. 1086-1095. by D. J. Cotter, K. Stefanik, Y. Zhang, M. Thamer, D. Scharfstein, J. Kaufman posted to anemia epo hd mortality surrogate by guhjy on 2009-01-24 03:45:05 as
	Prentice's Approach and the Meta-Analytic Paradigm: A Reflection on the Role of Statistics in the Evaluation of Surrogate Endpoints [My Copy] Biometrics, Vol. 60, No. 3. (2004), pp. 724-728. by Ariel Alonso, Geert Molenberghs, Tomasz Burzykowski, et al.Didier Renard, Helena Geys, Ziv Shkedy, Fabián Tibaldi, José C. Abrahantes, Marc Buyse posted to surrogate by guhjy on 2009-01-24 03:44:49 as along with 1 person cyberwulf
	A perfect correlate does not a surrogate make. [My Copy] BMC medical research methodology, Vol. 3 (9 September 2003) by S. G. Baker, B. S. Kramer posted to surrogate by guhjy on 2009-01-24 00:36:16 as
	Validation of creatinine-based estimates of GFR when evaluating risk factors in longitudinal studies of kidney disease. [My Copy] Journal of the American Society of Nephrology : JASN, Vol. 17, No. 10. (October 2006), pp. 2900-2909. by Xuelei Wang, Julia Lewis, Lawrence Appel, et al.DeAnna Cheek, Gabriel Contreras, Marquetta Faulkner, Harold Feldman, Jennifer Gassman, Janice Lea, Joel Kopple, Mohammed Sika, Robert Toto, Tom Greene posted to surrogate rct longitudinal gfr-slope gfr-formula creatinine ckd aask by guhjy on 2009-01-01 14:17:34 as
	NKF, FDA Host Conference to Assess Proteinuria as a Surrogate Outcome in Chronic Kidney Disease [My Copy] posted to ckd proteinuria rct surrogate uae by guhjy on 2009-01-01 12:43:20 as
	Evaluating a surrogate endpoint at three levels, with application to vaccine development [My Copy] Statistics in Medicine, Vol. 27, No. 23. (2008), pp. 4758-4778. by Peter B. Gilbert, Li Qin, Steven G. Self posted to surrogate by guhjy on 2009-01-01 03:28:43 as along with 1 person cyberwulf
	Biomarkers of intermediate endpoints in environmental and occupational health. [My Copy] International journal of hygiene and environmental health, Vol. 210, No. 3-4. (May 2007), pp. 461-470. by L. E. Knudsen, A. M. Hansen posted to environment surrogate by guhjy on 2008-11-21 03:43:47 as
	The use of surrogate endpoints to assess potential toxicity in humans. [My Copy] Toxicology letters, Vol. 120, No. 1-3. (31 March 2001), pp. 97-110. by A. G. Renwick, K. Walton posted to surrogate toxicology by guhjy on 2008-11-21 03:01:51 as
	Glucose lowering to control macrovascular disease in type 2 diabetes: treating the wrong surrogate end point? [My Copy] JAMA : the journal of the American Medical Association, Vol. 300, No. 17. (5 November 2008), pp. 2051-2053. by M. O. Goodarzi, B. M. Psaty posted to glycemia cv dm rct surrogate by guhjy on 2008-11-11 03:26:52 as along with 1 person booker
	Quantifying the Effect of the Surrogate Marker by Information Gain [My Copy] Biometrics, Vol. 63, No. 3. (September 2007), pp. 958-960. by Qu, Yongming, Case, Michael posted to surrogate by guhjy on 2008-10-31 04:16:40 as
	LDL-cholesterol differences predicted survival benefit in statin trials by the surrogate threshold effect (STE). [My Copy] Journal of clinical epidemiology (30 September 2008) by Kent R R. Johnson, Nick Freemantle, Danielle M M. Anthony, Marissa N D N. Lassere posted to mortality rct statin surrogate by guhjy on 2008-10-31 04:14:31 as
	Validity, credibility, and applicability: the rise and rise of the surrogate. [My Copy] British journal of anaesthesia, Vol. 101, No. 5. (November 2008), pp. 595-596. by J. G. Hardman, I. K. Moppett, R. P. Mahajan posted to rct surrogate by guhjy on 2008-10-31 04:11:55 as
	Two simple approaches for validating a binary surrogate endpoint using data from multiple trials. [My Copy] Statistical methods in medical research, Vol. 17, No. 5. (October 2008), pp. 505-514. by S. G. Baker posted to rct surrogate by guhjy on 2008-10-31 04:06:54 as
	Surrogate end points for graft failure and mortality in kidney transplantation [My Copy] Transplantation Reviews, Vol. 21, No. 2. (April 2007), pp. 97-106. by D. Hernandez, M. Rufino, J. Gonzalezposada, A. Torres, J. Pascual posted to mortality rt surrogate by guhjy on 2008-10-28 01:49:18 as
	On assessing surrogacy in a single trial setting using a semicompeting risks paradigm. [My Copy] Biometrics, Vol. 65, No. 2. (27 June 2009), pp. 521-529. by Debashis Ghosh posted to surrogate rct by guhjy on 2008-10-07 12:39:41 as
	Related causal frameworks for surrogate outcomes. [My Copy] Biometrics, Vol. 65, No. 2. (27 June 2009), pp. 530-538. by Marshall M. Joffe, Tom Greene posted to causation surrogate by guhjy on 2008-10-07 12:37:42 as along with 2 people cyberwulf peterwyang
	Does the decision in a validation process of a surrogate endpoint change with level of significance of treatment effect? A proposal on validation of surrogate endpoints. [My Copy] Contemporary clinical trials (9 September 2008) by Y Sertdemir, R Burgut posted to surrogate by guhjy on 2008-10-07 12:37:02 as
	Surrogate measures of outcome in clinical trials: clues worth examining? [My Copy] Neurosurgery, Vol. 63, No. 2. (August 2008) by B. S. Carter, I. A. Awad posted to outcome rct surrogate by guhjy on 2008-10-07 10:31:45 as
	Novel procedures for validating surrogate endpoints in clinical trials. [My Copy] Current clinical pharmacology, Vol. 2, No. 2. (May 2007), pp. 123-128. by T. J. Cleophas, A. H. Zwinderman, A. H. Chaib posted to rct surrogate by guhjy on 2008-09-27 16:17:38 as
	Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia. [My Copy] The New England journal of medicine, Vol. 356, No. 16. (19 April 2007), pp. 1620-1630. by J. J. Kastelein, S. I. van Leuven, L. Burgess, et al.G. W. Evans, J. A. Kuivenhoven, P. J. Barter, J. H. Revkin, D. E. Grobbee, W. A. Riley, C. L. Shear, W. T. Duggan, M. L. Bots, posted to cad hdl rct surrogate by guhjy on 2008-08-06 07:37:54 as
	Surrogate Marker Evaluation from an Information Theory Perspective [My Copy] Biometrics, Vol. 63, No. 1. (March 2007), pp. 180-186. by Alonso, Ariel, Molenberghs, Geert posted to surrogate by guhjy on 2008-07-28 15:00:14 as
	Flexible surrogate marker evaluation from several randomized clinical trials with continuous endpoints, using R and SAS [My Copy] Computational Statistics & Data Analysis, Vol. 51, No. 9. (15 May 2007), pp. 4152-4163. by Abel Tilahun, Assam Pryseley, Ariel Alonso, Geert Molenberghs posted to r rct sas software surrogate by guhjy on 2008-07-28 14:39:26 as
	Information-theory based surrogate marker evaluation from several randomized clinical trials with continuous true and binary surrogate endpoints. [My Copy] Clinical trials (London, England), Vol. 4, No. 6. (2007), pp. 587-597. by A. Pryseley, A. Tilahun, A. Alonso, G. Molenberghs posted to r rct software surrogate by guhjy on 2008-07-28 14:04:58 as
	Alternative methods to evaluate trial level surrogacy. [My Copy] Clinical trials (London, England), Vol. 5, No. 3. (2008), pp. 194-208. by J. C. Abrahantes, Z. Shkedy, G. Molenberghs posted to boosting surrogate by guhjy on 2008-07-28 14:01:37 as
	Evaluating Candidate Principal Surrogate Endpoints. [My Copy] Biometrics (24 March 2008) by Peter B B. Gilbert, Michael G G. Hudgens posted to r software surrogate by guhjy on 2008-07-28 10:14:22 as along with 2 people cyberwulf peterwyang
	Statistical challenges in the evaluation of surrogate endpoints in randomized trials. [My Copy] Controlled clinical trials, Vol. 23, No. 6. (December 2002), pp. 607-625. by G. Molenberghs, M. Buyse, H. Geys, D. Renard, T. Burzykowski, A. Alonso posted to rct surrogate by guhjy on 2008-07-28 05:18:30 as along with 1 person cyberwulf

Note: You may cite this page as: http://www.citeulike.org/user/guhjy/tag/surrogate

Result page: 1 2 Next

ckd	1742
rct	1203
dn	1118
cancer	1039
dm	1037
ma	979
cv	925
hd	859
tgfb	828
snp	766
bp	645
ros	606
meta-analysis	516
uae	500
kidney	496
stats	480
mouse	479
software	463
mirna	450
genetics	448
pt	439
proteomics	412
mortality	408
rat	378
fbl	371
inflammation	371
proteinuria	356
pcr	353
tw	347
db	337
acei	332
gdl	331
mtor	329
test	325
mc	322
inhibitor	322
akt	321
irs	319
1	317
method	316
arb	315
urine	315
ms	310
apoptosis	309
aging	308
age	305
hcv	304
r	294
biomarker	287
ppi	281
aii	280
hg	277
bias	277
bayes	275
gwa	269
aki	269
emt	260
nutrition	255
pi3k	253
s6k	253
rnai	248
p53	243
egfr	242
ub	241
fibrosis	236
obesity	235
cox	229
drug	225
smad	225
pbmc	223
hcc	215
metab	214
erk	214
hypoxia	211
gn	210
herb	204
nfkb	202
collagen	189
albumin	189
stz	186
lc	186
hif	182
longitudinal	179
lmm	178
pubmed	176
gfr	174
p38	170
ua	170
epigenetics	169
bioinf	165
japan	165
cea	163
power	163
gender	162
pkc	162
rage	161
dna-damage	161
lead	160
cadmium	158
ref	154
genomics	151
vitamin-d	148
stata	147
ctgf	147
network	146
liver	146
company	144
book	144
screening	137
rt	136
diet	136
mt	133
seq	133
phosphorylation	132
protein	128
go	128
kinase	128
pathway	127
cell-cycle	126
no	125
systems-biology	124
esrd	123
lipid	118
insulin	116
creatinine	115
statin	114
senescence	109
mapk	109
proliferation	108
podocyte	106
fish	104
regression	103
tnf	103
pd	102
case-control	102
gfr-formula	102
cad	102
imputation	101
multiplicity	100
rx	99
imaging	99
p21	98
observational	98
cloning	96
plasmid	96
pediatric	96
nox	95
stat	95
pparg	95
methylation	95
hypertrophy	95
recurrent	94
sirt	93
betel	93
blood	93
chf	91
nhanes	90
at1	89
src	89
website	89
anemia	88
immunity	88
phenotype	88
toxicology	87
diagnosis	87
lr	86
cytokine	85
uti	85
epo	84
ko	84
review	83
china	83
environment	82
p	81
oat	81
ca	81
cachexia	81
ebm	81
nonp	81
hapmap	80
primer	78
gout	78
autophagy	78
qms	77
gene-therapy	75
signaling	75
cox2	73
missing	73
promoter	73
gene-list	72
eif	72
eqtl	72
surrogate	72
stone	72
lpd	72
ace	71
egf	71
p-value	71
mv	71
salt	70
phd	69
4ebp	68
mgo	68
ampk	68
jnk	67
foxo	66
uncertainty	66
glycemia	66
gpcr	66
tin	66
hts	65
chinese	65
normalization	65
mirna-target	65
association	64
shc	64
2dge	63
yeast	63
causation	63
acid-base	63
enddysf	63
pla2	63
uuo	63
smoking	62
me	62
hsp	62
simulation	62
translation	62
oglcnac	61
avf	61
ptm	61
confounding	61
ifn	61
outcome	60
melamine	60
change	60
mmp	60
pe	60
sas	60
llcpk1	60
infection	60
crp	59
cost	59
oral	59
pai1	59
nrk49f	58
hk2	58
alcohol	58
model-selection	57
fluorescence	57
achr	57
pls	57
robust	57
urate-transporter	57
semantic	56
rho	56
pdgf	56
calibration	56
aceiarb	56
goldstd	55
ratio	55
ncrna	55
competing-risk	55
vegf	54
iron	54
stem-cell	54
estrogen	54
function	54
workflow	54
bone	54
ace2	54
ckd-progression	54
hsc	53
dipstick	53
pld	53
rapamycin	53
renoprotection	53
std	53
k	53
tf	52
cyclin-d1	52
histone	52
dimerization	52
atm	52
qc	52
il6	52
fgf	52
epidemiology	51
lod	51
pth	51
normoalbuminuria	51
ab	51
hdac	51
adpkd	50
reasoning	50
arsenic	50
matlab	50
mercury	50
graph	50
risk-ratio	50
gene-environment	49
wnt	49
epistasis	49
antibiotics	49
klotho	49
core-curriculum	48
p27	48
ukm	48
nrk52e	48
endothelium	48
ffpe	48
ngal	48
breakpoint	48
spot-urine	47
pooling	47
irs1	47
ecm	47
joint-model	47
cystatin	46
dub	46
fdr	46
protein-microarray	46
hgf	46
hepatocyte	46
aldosterone	46
aspirin	46
ras	45
writing	45
metal	45
mesangial	45
semip	45
prevention	45
pdk	45
biosensor	45
fgf23	45
ccb	44
ancova	44
variability	44
er-stress	44
interaction	44
sumo	44
diuretics	44
sle	43
bia	43
enos	43
na	43
dbdb	43
klf	43
cnv	43
design	43
good	42
icu	42
tgfbr	42
roc	42
mtorc1	42
asia	42
stroke	42
bmi	42
agreement	42
qtl	41
fuzzy	41
alignment	40
tlr	40
igf	40
gene-targeting	40
catenin	40
sage	40
wga	40
hyperfiltration	40
metformin	40
risk	40
rca	39
dry-bw	39
angiogenesis	39
urinalysis	39
ap1	39
tea	38
myc	38
rvh	38
omics	38
protein-complex	38
igan	38
animal	37
hematuria	37
gsk	37
adh	37
bh4	37
emr	37
propensity	37
fabp	37
haplotype	37
antisense	37
vsmc	37
web20	36
megalin	36
il1	36
adenosine	36
cardiorenal	36
proteasome	36
inflammasome	36
s100b	36
threshold	35
chemogenomics	35
candidate-gene	35
cre	35
reverse-epidemiology	35
calcification	35
subgroup	35
exercise	35
sp1	35
adduct	35
coffee	35
annotation	35
snx	35
attrition	34
sepsis	34
creb	34
pathology	34
nephrotoxicity	34
effect-size	34
rsk	34
fibronectin	34
gsk3	34
msm	34
cross-species	34
zeb	33
sarcopenia	33
bmp	33
integrin	33
ecology	33
cage	33
ns	33
macrophage	32
affy	32
browser	32
set	32
zfn	32
rtk	32
end-point	32
fc	32
orbitrap	32
ai	32
steroid	32
addgene	32
et	32
text-mining	32
family	31
hospitalization	31
abp	31
blast	31
emsa	31
frailty	31
transactivation	31
risk-difference	31
pka	31
heritability	31
sglt	31
gllamm	31
silac	31
mtorc2	31
geo	30
grn	30
mw	30
carcinogen	30
membrane-protein	30
reporter	30
s100	30
aa	30
knockout	30
transporter	30
notch	30
staging	30
nutrient	29
cr	29
pten	29
virus	29
nicotinic	29
perindopril	29
ub-ligase	29
validation	29
extraction	29
3	29
gee	28
scaling	28
race	28
acetylation	28
time-dependent	28
mutagenesis	28
pharmacogenetics	28
agt	27
classification	27
ndrd	27
thp	27
pdz	27
mendelian	27
igf1	27
hplc	27
cari	27
ck2	27

guhjy's surrogate [72 articles] Export

guhjy's tags